Seres Therapeutics is a biotherapeutic company that discovers and develops therapeutic products and drugs for the treatment of human diseases, such as infectious, metabolic, and inflammatory diseases. It is owned by Flagship VentureLabs founded by Noubar Afeyan and David Berry.
Timeline
October 2017
Seres Health raises a $2,500,000 grant from Carb-X.
January 2015
Seres Health raises a $65,000,000 series D round from Nestlé Health Science.
December 2014
Seres Health raises a $48,000,000 series C round from Flagship Pioneering.
May 2014
Seres Health raises a $10,000,000 series B round from Alexandria Venture Investments, Enso Ventures, Flagship Pioneering and Mayo Clinic.
November 2013
Seres Health raises a $10,500,000 series A round from Enso Ventures and Flagship Pioneering.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date